Cancer Research The Future of Cancer Research: Science and Patient Impact  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 57, 4718-4721, November 1, 1997]
© 1997 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Karlic, H.
Right arrow Articles by Heinz, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Karlic, H.
Right arrow Articles by Heinz, R.

Association of Human T-Cell Leukemia Virus and Myelodysplastic Syndrome in a Central European Population1

Heidrun Karlic2, Michaela Möstl, Hermann Mucke, Borislava Pavlova, Michael Pfeilstöcker and Renate Heinz

L. Boltzmann Institute for Leukemia Research and Hematology [H. K., B. P., R. H.] and 3rd Medical Department [M. M., M. P., R. H.], Hanusch Hospital, A-1140 Vienna, Austria, and Waldheim Pharmazeutika Research and Development Laboratory, A-1091 Vienna, Austria [H. M.]

In addition to a few disorders such as acute T-cell leukemia that are typically associated with the human T-cell leukemia virus (HTLV) 1 in endemic regions, this virus may also play a role in some other hematological diseases. Here, we examine the incidence of HTLV in hematological diseases from a nonendemic region in central Europe. Data obtained by PCR and/or serological techniques from a total of 730 cases showed that besides the expected presence of HTLV-1 in T-lymphoid diseases (2 of 27 cases), HTLV-1 was only detected in myelodysplastic syndrome (MDS), in which an incidence of 17% (11 of 65 cases) was found. A correlation with a history of multiple transfusions or treatment with blood products in the HTLV-1-positive MDS could not be ascertained. Cytogenetics detected the presence of del(5)(q) in six HTLV-positive cases (five MDS and one T-cell acute lymphocytic leukemia) but in only one HTLV-negative case. These data indicate that allelic deletions of a series of 5q-located genes that typically occur in MDS may be associated with HTLV infections in central Europe.

1 This work was supported by the Jubiläumsfonds der Österreichischen Nationalbank (Project No. 5179 and 6340) and by the Austrian Ministry of Health.

2 To whom requests for reprints should be addressed, at L. Boltzmann Institute for Leukemia Research and Hematology, Hanusch Hospital, Heinrich Collinstrasse 30, A-1140 Vienna, Austria. Phone: 43-1-91021-2346; Fax: 43-1-914-3214.

Received 7/ 7/97. Accepted 9/19/97.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1997 by the American Association for Cancer Research.